Glut3

Manufactured by Merck Group

Sourced in United States

Glut3 is a glucose transporter protein that facilitates the movement of glucose across cell membranes. It plays a crucial role in cellular glucose uptake and distribution within the body.

Automatically generated - may contain errors

Lab products found in correlation

Wzb117, by Merck Group (1 mentions) Mg132, by Merck Group (1 mentions) Fty720, by Merck Group (1 mentions) Phloretin, by Merck Group (1 mentions) Glut1, by Abcam (1 mentions) Empagliflozin, by Selleck Chemicals (1 mentions) Dapagliflozin, by Selleck Chemicals (1 mentions) Lamin b, by Cell Signaling Technology (1 mentions) Canagliflozin, by Selleck Chemicals (1 mentions) Mouse igg2b apc, by Miltenyi Biotec (1 mentions) Fitc anti human cd326 epcam, by BioLegend (1 mentions) Mouse igg2b fitc, by BioLegend (1 mentions) Pp2ac, by Merck Group (1 mentions) Anti rabbit igg hrp linked antibody, by Cell Signaling Technology (1 mentions) Gsk3b, by Cell Signaling Technology (1 mentions) β actin, by Cell Signaling Technology (1 mentions) β tubulin, by Cell Signaling Technology (1 mentions) Glut1, by Santa Cruz Biotechnology (1 mentions) Rsk1 rsk2 rsk3, by Cell Signaling Technology (1 mentions) Hsp60, by Cell Signaling Technology (1 mentions)

Spelling variants of this product

GLUT1 and GLUT3 antibody (2 citations)

2 protocols using glut3

Phospho-β-catenin Signaling Pathway Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Canagliflozin, empagliflozin, and dapagliflozin were purchased from Selleck Chemicals (Houston, TX). MG-132, lithium chloride (LiCl), FTY720, WZB117, and phloretin were obtained from Sigma-Aldrich (St. Louis, MO) and Okadaic acid (OA) was from Cayman Chemical (Ann Arbor, MI). For immunoblotting, antibodies against phospho-β-catenin (Ser33/Ser37/Thr41), phospho-β-catenin (Ser45), β-catenin, Cyclin D1, Tubulin, Lamin B, and DDK-tag were purchased from Cell Signaling (Danvers, MA), and Glut1 and GAPDH antibodies were from Abcam (Cambridge, MA). PP2Ac, Glut3, and Actin antibodies were obtained from Millipore (Billerica, MA), Santa Cruz Biotechnology (San Diego, CA), and ProteinTech (Rosemont, IL), respectively. For experiments related to flow cytometry, Monoclonal CD133/2 (293C3)-APC and Mouse-IgG2b-APC antibodies were purchased from Miltenyi Biotech (Bergish Gladbach, Germany), and FITC anti-human CD326 (EpCAM) and Mouse-IgG2b-FITC antibodies were from BioLegend (San Diego, CA).

Hung M.H., Chen Y.L., Chen L.J., Chu P.Y., Hsieh F.S., Tsai M.H., Shih C.T., Chao T.I., Huang C.Y, & Chen K.F. (2019). Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation. Cell Death & Disease, 10(6), 420.

+ Open protocol

+ Expand

Immunoblotting Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Immunoblots were conducted with the following primary antibodies all used at 1:1000: Hexokinase II (cat. no. 2867; Cell Signaling Technology, Danvers, MA, USA), Beta Actin (cat. no. 4970; Cell Signaling), Beta Tubulin (cat. no. 2128; Cell Signaling), GSK3B (cat. no. 9315), p-GSK3B S9 (cat. no. 9323; Cell Signaling), p-p90RSK T573 (cat. no. 9346; Cell Signaling), RSK1/RSK2/RSK3 (cat. no. 9355; Cell Signaling), hsp60 (cat. no. sc-1052; Santa Cruz Biotechnology, Santa Cruz, CA, USA), GLUT1 (cat. no. 07-1401; Millipore, Billerica, MA, USA), GLUT3 (cat. no. NBP1-89762; Novus Biologicals, Littleton, CO, USA) and the secondary antibody Anti-rabbit IgG, HRP-linked Antibody (cat. no. 7074S; Cell Signaling).

Theodosakis N., Held M.A., Marzuka-Alcala A., Meeth K.M., Micevic G., Long G.V., Scolyer R.A., Stern D.F, & Bosenberg M.W. (2015). BRAF inhibition decreases cellular glucose uptake in melanoma in association with reduction in cell volume. Molecular cancer therapeutics, 14(7), 1680-1692.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!